APLS logo

Apellis Pharmaceuticals, Inc. (APLS) Cash from investing

annual CFI:

-$403.00K+$271.00K(+40.21%)
December 31, 2024

Summary

  • As of today (August 4, 2025), APLS annual cash flow from investing activities is -$403.00 thousand, with the most recent change of +$271.00 thousand (+40.21%) on December 31, 2024.
  • During the last 3 years, APLS annual CFI has fallen by -$248.02 million (-100.16%).
  • APLS annual CFI is now -100.16% below its all-time high of $247.62 million, reached on December 31, 2021.

Performance

APLS Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLScash flow metrics

quarterly CFI:

-$49.00K-$41.00K(-512.50%)
June 30, 2025

Summary

  • As of today (August 4, 2025), APLS quarterly cash flow from investing activities is -$49.00 thousand, with the most recent change of -$41.00 thousand (-512.50%) on June 30, 2025.
  • Over the past year, APLS quarterly CFI has increased by +$41.00 thousand (+45.56%).
  • APLS quarterly CFI is now -100.02% below its all-time high of $198.76 million, reached on September 30, 2020.

Performance

APLS quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLScash flow metrics

TTM CFI:

-$77.00K+$41.00K(+34.75%)
June 30, 2025

Summary

  • As of today (August 4, 2025), APLS TTM cash flow from investing activities is -$77.00 thousand, with the most recent change of +$41.00 thousand (+34.75%) on June 30, 2025.
  • Over the past year, APLS TTM CFI has increased by +$349.00 thousand (+81.92%).
  • APLS TTM CFI is now -100.02% below its all-time high of $331.58 million, reached on March 31, 2023.

Performance

APLS TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLScash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

APLS Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+40.2%+45.6%+81.9%
3 y3 years-100.2%-100.1%-100.1%
5 y5 years+76.2%+100.0%+100.0%

APLS Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.2%+40.2%-100.0%+86.8%-100.0%+89.1%
5 y5-year-100.2%+99.9%-100.0%+100.0%-100.0%+100.0%
alltimeall time-100.2%+99.9%-100.0%+100.0%-100.0%+100.0%

APLS Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$49.00K(+512.5%)
-$77.00K(-34.7%)
Mar 2025
-
-$8000.00(-60.0%)
-$118.00K(-70.7%)
Dec 2024
-$403.00K(-40.2%)
-$20.00K(<-9900.0%)
-$403.00K(+6.3%)
Sep 2024
-
$0.00(-100.0%)
-$379.00K(-11.0%)
Jun 2024
-
-$90.00K(-69.3%)
-$426.00K(-39.8%)
Mar 2024
-
-$293.00K(-7425.0%)
-$708.00K(+5.0%)
Dec 2023
-$674.00K(-101.1%)
$4000.00(-108.5%)
-$674.00K(-100.5%)
Sep 2023
-
-$47.00K(-87.4%)
$123.45M(-50.3%)
Jun 2023
-
-$372.00K(+43.6%)
$248.28M(-25.1%)
Mar 2023
-
-$259.00K(-100.2%)
$331.58M(+453.6%)
Dec 2022
$59.89M(-75.8%)
$124.13M(-0.5%)
$59.89M(+188.7%)
Sep 2022
-
$124.78M(+50.5%)
$20.74M(-72.6%)
Jun 2022
-
$82.93M(-130.5%)
$75.61M(-38.2%)
Mar 2022
-
-$271.95M(-420.0%)
$122.43M(-50.6%)
Dec 2021
$247.62M
$84.98M(-52.7%)
$247.62M(+52.3%)
Sep 2021
-
$179.65M(+38.5%)
$162.54M(-10.5%)
DateAnnualQuarterlyTTM
Jun 2021
-
$129.75M(-188.4%)
$181.66M(-177.0%)
Mar 2021
-
-$146.76M(>+9900.0%)
-$235.90M(-25.6%)
Dec 2020
-$316.99M(>+9900.0%)
-$91.00K(-100.0%)
-$316.99M(-0.0%)
Sep 2020
-
$198.76M(-169.1%)
-$317.05M(-38.6%)
Jun 2020
-
-$287.81M(+26.3%)
-$516.29M(+125.8%)
Mar 2020
-
-$227.85M(>+9900.0%)
-$228.67M(>+9900.0%)
Dec 2019
-$1.69M(<-9900.0%)
-$155.00K(-67.1%)
-$1.69M(+10.1%)
Sep 2019
-
-$471.00K(+145.3%)
-$1.54M(+44.1%)
Jun 2019
-
-$192.00K(-78.1%)
-$1.07M(+21.9%)
Mar 2019
-
-$875.00K(<-9900.0%)
-$875.00K(<-9900.0%)
Dec 2018
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00
$0.00
Dec 2017
$0.00(-100.0%)
-
-
Dec 2014
-$19.90K(<-9900.0%)
-
-
Dec 2013
$0.00
-
-

FAQ

  • What is Apellis Pharmaceuticals, Inc. annual cash flow from investing activities?
  • What is the all time high annual CFI for Apellis Pharmaceuticals, Inc.?
  • What is Apellis Pharmaceuticals, Inc. annual CFI year-on-year change?
  • What is Apellis Pharmaceuticals, Inc. quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Apellis Pharmaceuticals, Inc.?
  • What is Apellis Pharmaceuticals, Inc. quarterly CFI year-on-year change?
  • What is Apellis Pharmaceuticals, Inc. TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Apellis Pharmaceuticals, Inc.?
  • What is Apellis Pharmaceuticals, Inc. TTM CFI year-on-year change?

What is Apellis Pharmaceuticals, Inc. annual cash flow from investing activities?

The current annual CFI of APLS is -$403.00K

What is the all time high annual CFI for Apellis Pharmaceuticals, Inc.?

Apellis Pharmaceuticals, Inc. all-time high annual cash flow from investing activities is $247.62M

What is Apellis Pharmaceuticals, Inc. annual CFI year-on-year change?

Over the past year, APLS annual cash flow from investing activities has changed by +$271.00K (+40.21%)

What is Apellis Pharmaceuticals, Inc. quarterly cash flow from investing activities?

The current quarterly CFI of APLS is -$49.00K

What is the all time high quarterly CFI for Apellis Pharmaceuticals, Inc.?

Apellis Pharmaceuticals, Inc. all-time high quarterly cash flow from investing activities is $198.76M

What is Apellis Pharmaceuticals, Inc. quarterly CFI year-on-year change?

Over the past year, APLS quarterly cash flow from investing activities has changed by +$41.00K (+45.56%)

What is Apellis Pharmaceuticals, Inc. TTM cash flow from investing activities?

The current TTM CFI of APLS is -$77.00K

What is the all time high TTM CFI for Apellis Pharmaceuticals, Inc.?

Apellis Pharmaceuticals, Inc. all-time high TTM cash flow from investing activities is $331.58M

What is Apellis Pharmaceuticals, Inc. TTM CFI year-on-year change?

Over the past year, APLS TTM cash flow from investing activities has changed by +$349.00K (+81.92%)
On this page